GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jenburkt Pharmaceuticals Ltd (BOM:524731) » Definitions » Short-Term Capital Lease Obligation

Jenburkt Pharmaceuticals (BOM:524731) Short-Term Capital Lease Obligation : ₹4 Mil (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Jenburkt Pharmaceuticals Short-Term Capital Lease Obligation?

Jenburkt Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₹4 Mil.

Jenburkt Pharmaceuticals's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 (₹4 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹4 Mil).

Jenburkt Pharmaceuticals's annual Short-Term Capital Lease Obligation declined from Mar. 2023 (₹5 Mil) to Mar. 2024 (₹0 Mil) but then increased from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹4 Mil).


Jenburkt Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Jenburkt Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jenburkt Pharmaceuticals Short-Term Capital Lease Obligation Chart

Jenburkt Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.17 4.51 4.89 - 4.23

Jenburkt Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 4.07 - 4.23

Jenburkt Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Jenburkt Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Jenburkt Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Jenburkt Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
93, Jayprakash Road, Nirmala Apartments, Andheri (West), Mumbai, MH, IND, 400058
Jenburkt Pharmaceuticals Ltd is engaged in the manufacturing, producing, developing, and marketing of pharmaceutical formulations. The company operates in one segment - pharmaceutical formulations. The company generates key revenue from the local market.

Jenburkt Pharmaceuticals Headlines

No Headlines